A 55-year-old female with type 2 diabetes (T2D) and chronic kidney disease (CKD) presented to the ambulatory care clinic. Her T2D was previously managed with metformin plus an SGLT2 inhibitor, but the SGLT2 inhibitor was discontinued recently due to recurring yeast infections. Her primary care provider (PCP) referred her to pharmacy for a diabetes consult and evaluation for alternative agents (following discontinuation of the SGLT2 inhibitor) to slow progression of her CKD. |
